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Racial and Ethnic Differences in Serum
Cotinine Levels of Cigarette Smokers
Third National Health and Nutrition Examination Survey,
1988-1991
Ralph S. Caraballo, PhD; Gary A. Giovino, PhD; Terry F. Pechacek, PhD; Paul D. Mowery, MS;
Patricia A. Richter, PhD; Warren J. Strauss, ScM; Donald J. Sharp, MD; Michael P. Eriksen, ScD;
James L. Pirkle, MD, PhD; Kurt R. Maurer, PhD

Context.—Cotinine, a metabolite of nicotine, is a marker of exposure to tobacco
smoke. Previous studies suggest that non-Hispanic blacks have higher levels of serum cotinine than non-Hispanic whites who report similar levels of cigarette smoking.
Objective.—To investigate differences in levels of serum cotinine in black, white,
and Mexican American cigarette smokers in the US adult population.
Design.—Third National Health and Nutrition Examination Survey, 1988-1991.
Participants.—A nationally representative sample of persons aged 17 years or
older who participated in the survey.
Outcome Measures.—Serum cotinine levels by reported number of cigarettes
smoked per day and by race and ethnicity.
Results.—A total of 7182 subjects were involved in the study; 2136 subjects reported smoking at least 1 cigarette in the last 5 days. Black smokers had cotinine
concentrations substantially higher at all levels of cigarette smoking than did white
or Mexican American smokers (P,.001). Serum cotinine levels for blacks were
125 nmol/L (22 ng/mL) (95% confidence interval [CI], 79-176 nmol/L [14-31 ng/mL])
to 539 nmol/L (95 ng/mL) (95% CI, 289-630 nmol/L [51-111 ng/mL]) higher than
for whites and 136 nmol/L (24 ng/mL) (95% CI, 85-182 nmol/L [15-32 ng/mL]) to
641 nmol/L (113 ng/mL) (95% CI, 386-897 nmol/L [68-158 ng/mL]) higher than for
Mexican Americans. These differences do not appear to be attributable to
differences in environmental tobacco smoke exposure or in number of cigarettes
smoked.
Conclusions.—To our knowledge, this study provides the first evidence from a
national study that serum cotinine levels are higher among black smokers than
among white or Mexican American smokers. If higher cotinine levels among blacks
indicate higher nicotine intake or differential pharmacokinetics and possibly serve
as a marker of higher exposure to cigarette carcinogenic components, they may
help explain why blacks find it harder to quit and are more likely to experience higher
rates of lung cancer than white smokers.
JAMA. 1998;280:135-139
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THE BIOCHEMICAL measurement of
serum cotinine, the primary metabolite of
nicotine, is widely applied as a marker of
both tobacco use and exposure to environmental tobacco smoke (ETS). Previous
studies1-4 have suggested that non-Hispanic blacks have higher levels of serum
cotinine than do non-Hispanic whites who
report similar levels of cigarette smoking.
The interpretation of the results in these
studies has been subject to debate, how-
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ever.3,5-8 Some researchers3,6,7 have suggested that differences between levels
of serum cotinine in non-Hispanic black
smokers and non-Hispanic white smokers are attributable, at least in part, to
racial differences in nicotine metabolism
or elimination. Others5 believe that such
differences are attributable to other variables, including differences in the type
of cigarette smoked (length of cigarette,
menthol or nonmenthol, filter or nonfilter,
and nicotine yield) and differences in how
the cigarettes are smoked (blocking ventilation holes by fingers or lips, frequency
and depth of inhalation, retention time of
smoke in the lungs, and percentage of
available tobacco smoked). Serum cotinine differences by race have also been
attributed to differences in the accuracy
of cigarette smoking self-reports2,9-12 and
to differences in exposure to ETS.4,13,14
See also pp 152 and 179.
Cotinine is widely applied as a marker
of both tobacco use and exposure to environmental tobacco smoke (ETS) because it has a longer half-life (average, 18
to 20 hours) than nicotine does (average,
2 to 3 hours). On average, a cigarette
smoker absorbs about 1 mg of nicotine per
cigarette smoked.15,16 The increment in
blood nicotine concentration after smoking a single cigarette ranges from 0.031
to 0.185 µmol/L (5-30 ng/mL), depending
on how the cigarette is smoked.17-19 An average of 70% to 80% of the nicotine absorbed is metabolized to cotinine.16,20-23
In adult smokers, a nicotine intake of
approximately 1 mg can be estimated
from a blood cotinine level of 71 nmol/L
(12.5 ng/mL) using a conversion factor of
0.08 mg/24 h per nanogram per milliliter
under steady-state conditions.14 The co-
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efficient of variation of the correction factor is 22%, however, and does not take into
account possible racial or ethnic differences in the conversion of nicotine to
cotinine.
Scientists at the National Center for
Environmental Health of the Centers for
Disease Control and Prevention recently
developed a new, highly sensitive biochemical measurement method for detecting levels of serum cotinine as low as
0.3 nmol/L (0.05 ng/mL). Using the new
method, we investigated racial and ethnic differences in serum cotinine levels.
We obtained data on serum cotinine levels from a representative sample of adult
smokers and nonsmokers of the third National Health and Nutrition Examination
Survey (NHANES III), a nationwide
household collection of health and nutritional information from a representative
sample of the US civilian, noninstitutionalized population aged 2 months or older.
METHODS
The NHANES III, conducted from
1988 to 1994, consisted of a number of
questionnaires performed in the household followed by standardized physical
examinations and additional tobacco use
questions administered in specially
equipped mobile examination centers
(MECs). We used NHANES III phase 1
data collected between October 25, 1988,
and October 21, 1991, because the data
for some of the key variables for the
analyses were available for only this 3year period. The nationally representative sample of the eligible population
surveyed during phase 1 permitted calculation of national estimates.
Subjects and Demographics
Our study sample was limited to participants aged 17 years or older who described themselves as non-Hispanic
blacks, non-Hispanic whites, or Mexican
Americans, who had a serum cotinine
measurement and provided tobacco use
information in the MEC, and who did not
use any other significant sources of nicotine in the previous 5 days. Of the 12 391
persons selected, 2271 refused the interview; 1315 were interviewed at home and
did not visit the MECs; 281 did not answer
the MEC tobacco questionnaire; 682 had
no cotinine measurement; 434 reported
using other significant sources of nicotine
in the previous 5 days; and 226 were other
than non-Hispanic white, non-Hispanic
black, and Mexican American. Data from
2136 subjects who reported smoking 1
cigarette or more in the past 5 days were
included in the analyses. One of the analyses included data from both smokers and
nonsmokers (n = 7182).
Race and ethnicity based on self-report
were categorized as non-Hispanic black,

non-Hispanic white (henceforth referred
to as blacks and whites), and Mexican
American. Age at interview was categorized as 17 to 24, 25 to 44, 45 to 64, or 65 or
moreyears.Educationallevelwascategorized as 0 to 8, 9 to 11, 12, or 13 or more
completed years of schooling. Poverty
status was based on a measure developed
by the US Bureau of the Census. Members of families whose incomes were equal
to or greater than poverty thresholds
were categorized as “at or above poverty
level”; those with family incomes below
the poverty threshold, as “below poverty
level.” Each subject’s weight in kilograms,measuredusingadigitalscale,was
categorized as less than 60, 60 to 69.99, 70
to 79.99, and 80 kg or more.
Reported exposure to ETS at home
was based on the following questions
posed to 1 member of the household (usually the head of the family or spouse of
the head): “Does anyone who lives here
smoke cigarettes in the home?” When the
answer was yes, the interviewee was then
asked: “Who?” When any household
member smoked, each member of that
household was classified as being exposed
to ETS at home. The number of household
members who smoked was categorized as
0, 1, or 2 or more. In addition, one of the
family members was asked how many
rooms were in the home, excluding bathrooms. The number of rooms in the home
was categorized as 1 to 4 or 5 or more.
Persons aged 17 years or older who reported having a job or business were also
asked how many hours per day they were
close enough to tobacco smoke at work
that they could smell the smoke. The number of hours exposed to ETS at work was
categorized as 0, 1 to 3, or 4 or more. Data
were also categorized by region as Northeast, North Central, South, or West, according to standard US Bureau of the
Census definitions.
The MEC tobacco questionnaire asked
participants: “How many cigarettes have
you smoked in the past 5 days?” A smoker
was defined as a person who reported
smoking 1 cigarette or more during the
previous 5 days. The average number of
cigarettes smoked per day was calculated
and used for the analyses.
Serum Cotinine Measurement
Biochemical determination of tobacco
exposurewasperformedbymeasuringserum cotinine levels in blood specimens obtained by venipuncture in the MEC. The
cotinine assay involved isotope dilution,
liquid chromatography, and tandem mass
spectrometry.24 As in the study by Pirkle
and colleagues,13 we used cutoff points of
higher than 85 nmol/L (15 ng/mL) and 85
nmol/L (15 ng/mL) or less of cotinine in
serum to designate active tobacco users
and nontobacco users, respectively.
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Cotinine data were originally reported in nanograms per milliliter. A
conversion factor of 5.67 was used to convert cotinine levels in nanograms per
milliliter to cotinine levels in nanomoles
per liter, based on a molecular weight for
cotinine of 176.22. A conversion factor of
0.006 was used to convert nicotine levels
previously reported in nanograms per
milliliter to nicotine levels in micromoles/liter, based on a molecular weight
for nicotine of 162.23.
Statistical Analysis
Determination of serum cotinine levels
by race and ethnicity involved fitting a
series of nonlinear exponential regression models of the form: ln(cotinine)
= b0 − b1exp( − b2 O) + error, where ln(cotinine) is the natural logarithm of serum
cotinine; O is the number of self-reported
cigarettes smoked per day; b0, b1, and b2
are parameters that describe the exponential relationship; and error is the
residual error left unexplained by the
model. This exponential model facilitated
modeling serum cotinine as a monotonically increasing function of the number of
cigarettes smoked, with cotinine increasing at a decreasing rate toward an upper
asymptote. The variable b0 represents
the upper bound (maximum achievable
level) of ln(cotinine) at the highest levels
of daily smoking, and b2 represents the
rate at which cotinine increases with consumption. The quantity (b0 − b1) represents the expected ln(cotinine) at a consumption level of 0 cigarettes per day.
Prior to model fitting, we divided the selfreported number of cigarettes smoked in
the last 5 days by 5 and rounded to the
nearest integer. Therefore, in the model,
less than 1 represents a response of 1 to 4
cigarettes smoked in the last 5 days.
We fit 3 exponential models, one for each
racial or ethnic group, and used weights
supplied with the NHANES III data set
to make the results more applicable to the
US population. After fitting the simple exponential model, a series of covariate adjusted models were fit to the data from
each racial and ethnic group. These models investigated the relationship between
serum cotinine and cigarettes smoked per
day after adjustment for each of the following covariates: sex, number of smokers in the household, hours of exposure to
ETS at work, age, and weight.
The more complicated models were fit
by adding covariates one at a time to the
base model in an ordered sequence determined by the results of an F test of
significance for each variable when
added individually to the base model. We
assessed the adequacy of the fit of the
exponential regression models by using
plots of the studentized residuals vs
the predicted values. The assumption of
Cotinine Differences by Ethnicity—Caraballo et al
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normally distributed cotinine data was
assessed using normal probability plots
applied to the studentized residuals.
We used the appropriate weights and
computed the complex variance estimates using SUDAAN25 in all analyses.

Table 1.—Study Sample Distribution of 2136 Self-reported Smokers Aged 17 Years or Older, by Race/
Ethnicity and Sociodemographic Characteristics, NHANES III, United States, 1988-1991*

Characteristic
Sex
Male
Female

No. (%) of
Non-Hispanic Blacks
(n = 665)

No. (%) of
Non-Hispanic Whites
(n = 900)

No. (%) of
Mexican Americans
(n = 571)

365 (55)

465 (52)

374 (66)

300 (45)

435 (48)

197 (34)

RESULTS
Study Population
Proportionately more black smokers
than white smokers were poor and
weighed 80 kg or more (Table 1). In
terms of sociodemographic characteristics, Mexican American smokers differed from other racial and ethnic groups
of smokers more than either their white
or black counterparts.
Among self-reported smokers, both
blacks and whites had serum cotinine levels consistent with their reported smoking levels (Table 2). Therefore, among
blacks and whites, the ability of the biochemical measurement to detect smokers
and nonsmokers was similar. Self-reported Mexican American smokers were
less likely than blacks or whites to have
serum cotinine levels consistent with
their reported smoking levels. Self-reported nonsmokers (97.9% of blacks,
98.5% of whites, and 99.4% of Mexican
Americans) had biochemically assessed
cotinine threshold levels consistent with
their reported smoking levels.
Self-reported and biochemically assessed smoking prevalences among blacks
(34.9% and 34.7%, respectively) were similar to those for whites (33.1%, 32.1%) and
higher than Mexican Americans (27.0%,
20.1%) (results not shown). Although
blacks were as likely to have smoked in
the past 5 days as whites, they reported
smoking fewer cigarettes per day than
whites (Table 3). Mexican Americans
smoked fewer cigarettes per day than did
either blacks or whites.

Age, y
17-24

104 (16)

152 (17)

148 (26)

25-44

324 (49)

358 (40)

255 (45)

45-64

181 (27)

255 (28)

120 (21)

56 (8)

135 (15)

48 (8)

Statistics and Modeling
Fitting a nonlinear exponential unadjusted regression model (Figure) to determine the relationship between serum
cotinine levels and self-reported cigarette smoking showed that cotinine concentrations were substantially higher
among black smokers than among white
or Mexican American smokers at all levels of cigarette smoking. Whites and
Mexican Americans had similar serum
cotinine levels when they smoked up to 5
cigarettes per day, but serum cotinine
levels increased significantly more for
whites than for Mexican Americans with
each additional cigarette smoked. Serum
cotinine levels for blacks were 125 nmol/L
(22 ng/mL) (95% confidence interval [CI],
79-176 nmol/L [14-31 ng/mL]) to 539
nmol/L (95 ng/mL) (95% CI, 289-630
nmol/L [51-111 ng/mL]) higher than for

Race/Ethnicity and
Self-reported Smoking Status
Blacks
Smoker

$65
Education, y
0-8

70 (11)

79 (9)

228 (41)

9-11

189 (28)

179 (20)

131 (23)

12

263 (40)

360 (40)

131 (23)

$13

140 (21)

275 (31)

74 (13)

Poverty status
, Poverty level

279 (42)

173 (19)

296 (52)

$ Poverty level

386 (58)

727 (81)

275 (48)

Weight, kg
,60

110 (18)

200 (24)

113 (21)

60-60.99

147 (23)

167 (20)

143 (27)

70-79.99

144 (23)

221 (26)

117 (22)

224 (36)

253 (30)

159 (30)
155 (27)

$80
No. of smokers in home
0

58 (9)

99 (11)

355 (54)

371 (41)

254 (45)

$2
No. of rooms in home
1-4

249 (37)

430 (48)

161 (28)

204 (31)

245 (27)

261 (46)

$5
Tobacco exposure at work, h
0

461 (69)

655 (73)

310 (54)

414 (64)

477 (54)

382 (69)

74 (11)

124 (14)

75 (13)

163 (25)

280 (32)

100 (18)

1

1-3
$4
US region
Northeast

103 (16)

179 (20)

6 (1)

North Central

182 (27)

243 (27)

48 (8)

South

333 (50)

347 (38)

164 (29)

West

47 (7)

131 (15)

353 (62)

*NHANES III indicates third National Health and Nutrition Examination Survey.
Table 2.—Agreement Between Self-reported Smoking Status and Cotinine Levels of 7182 Smokers and
Nonsmokers Aged 17 Years or Older, by Race/Ethnicity, NHANES III, United States, 1988-1991*
Cotinine Level
.85 nmol/L (15 ng/mL),
No. (% ± 95% CI)

Nonsmoker
Whites
Smoker
Nonsmoker
Mexican Americans
Smoker
Nonsmoker

#85 nmol/L (15 ng/mL),
No. (% ± 95% CI)

Total

632 (95.5 ± 2.0)

33 (4.5 ± 2.0)

665

30 (2.1 ± 0.6)

1129 (97.9 ± 0.6)

1159

849 (93.8 ± 1.7)

51 (6.2 ± 1.7)

900

42 (1.5 ± 0.5)

2299 (98.5 ± 0.5)

2341

426 (72.5 ± 7.4)

145 (27.5 ± 7.4)

571

10 (0.6 ± 0.5)

1536 (99.4 ± 0.5)

1546

*NHANES III indicates third National Health and Nutrition Examination Survey; CI, confidence interval.

whites and 136 nmol/L (24 ng/mL) (95%
CI, 85-182 nmol/L [15-32 ng/mL]) to 641
nmol/L (113 ng/mL) (95% CI, 386-897
nmol/L [68-158 ng/mL]) higher than for
Mexican Americans. Verification of the
results of this analysis by unweighted
analysis yielded similar results. Previous
analyses had revealed that variables such
as education, poverty status, time of day

JAMA, July 8, 1998—Vol 280, No. 2

the blood was drawn, number of rooms in
the house, and geographic region were
not significantly associated with serum
cotinine (data not shown). These variables were excluded from the final model
in this study.
An F test comparing a full model (adjusting the relationship for the effects of
race and ethnicity, age, sex, body weight,
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Cigarettes
per Day

Non-Hispanic Blacks,
No. (% ± 95% CI)

Non-Hispanic Whites,
No. (% ± 95% CI)

Mexican Americans,
No. (% ± 95% CI)

,1

41 (6.2 ± 2.3)

45 (5.5 ± 1.7)

127 (24.3 ± 6.1)

1-7
8-14

200 (30.1 ± 3.7)
193 (29.3 ± 2.8)

120 (12.6 ± 2.1)
152 (17.7 ± 3.0)

240 (41.7 ± 3.9)
111 (17.9 ± 3.5)

15-24

186 (27.8 ± 3.8)

315 (36.5 ± 3.5)

80 (13.4 ± 2.8)

$25
Total

45 (6.6 ± 1.7)
665 (100.0)

268 (27.7 ± 4.5)
900 (100.0)

13 (2.7 ± 1.5)
571 (100.0)

*NHANES III indicates third National Health and Nutrition Examination Survey; CI, confidence interval.
Table 4.—Sequential F Tests and Associated P Values for Each Covariate When Added to the Previous
Weighted Nonlinear Exponential Regression Model for 2127 Smokers Aged 17 Years or Older, by
Race/Ethnicity, NHANES III, United States, 1988-1991*

Serum Cotinine Level, nmol/L (ng/mL)

Table 3.—Percentage of 2136 Self-reported Smokers Aged 17 Years or Older, by Number of Cigarettes
Smoked per Day in the Past 5 Days and by Race/Ethnicity, NHANES III, United States, 1988-1991*

2840 Non-Hispanic
(500)
Blacks

568
(100)
Non-Hispanic
Whites
57
(10)

6 (1)
<1

Mexican
Americans

5

10

15

20

25

30

No. of Cigarettes Smoked per Day
Blacks, Covariates Added

Result
F
P
No.

Base
Model

No. of Smokers
in Home

Body Weight
Category

Age
Category

Hours of Work
Exposure to Smoke

Sex

1258
,.001

4.65
,.001

3.75
,.001

2.36
.01

1.16
.33

0.59
.62

662

656

647

638

632

629

No. of Smokers
in Home
3.26
.004
873

Body Weight
Category
2.28
.02
864

Whites, Covariates Added

Result

Base
Model

F
P
No.

116
,.001
897

Hours of Work
Exposure to Smoke
7.97
,.001
891

Age
Category
3.62
,.001
879

Sex
5.84
,.001
888

Mexican Americans, Covariates Added

Result

Base
Model

F
P
No.

3794
,.001
568

Hours of Work
Exposure to Smoke
4.26
,.001
562

No. of Smokers
in Home
3.36
.003
556

Age
Category
1.72
.08
547

Body Weight
Category
1.64
.10
538

Sex
0.45
.72
535

*NHANES III indicates third National Health and Nutrition Examination Survey.

and ETS exposure at home and at work)
with a reduced model (adjusting for only
the effects of age, sex, body weight, and
ETS exposure at home and at work)
showed the statistical significance of persistent racial and ethnic differences in the
relationship between serum cotinine and
self-reported cigarette smoking (after adjustment for other covariates, P,.001).
For blacks, the number of smokers living in the home, body weight, and age, in
that order, explained significant reductions in variability of serum cotinine levels (Table 4). For whites, the number of
hours of ETS exposure at work, sex, age,
the number of smokers living in the
home, and body weight were of descending importance in explaining significantly reduced variability of serum
cotinine levels. And for Mexican Americans, 2 covariates were responsible for
reducing this variability: the number of
hours of ETS exposure at work and the
number of smokers living in the home.
COMMENT
This study provides the first evidence
from a national study that black smokers
have higher serum cotinine levels than do
white or Mexican American smokers, after adjustment for the number of ciga-

rettes smoked per day, age, sex, body
weight, number of smokers living in the
home, and number of hours exposed at
work to ETS. Our finding is consistent with
the results of previous smaller studies1-4
that have found that blacks have higher
serum cotinine levels than whites do at
similar levels of self-reported smoking, but
differs from that of 1 previous report12 suggesting that Mexican Americans derive
more cotinine per cigarette than whites do.
The analysis in our study was limited
by the lack of data on the type of cigarette
smoked (eg, menthol vs regular or filter
vs nonfilter), smoking topography (eg,
depth of inhalation or vent blocking),
or nicotine pharmacokinetics. Previous
studies have assessed the contribution of
some of these factors (eg, the use of mentholated or nonmentholated cigarettes) to
serum cotinine levels among black smokers and white smokers. Some of these
studies1,26-28 have reported that smokers
of mentholated cigarettes have higher
levels of serum cotinine than smokers
of nonmentholated cigarettes; others3,29
have reported no significant differences.
More blacks (76%) than whites (23%) prefer mentholated cigarettes.30,31
In a study of 5115 young adults,3 Wagenknecht and colleagues found that the
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Correlation between serum cotinine levels and
number of cigarettes smoked per day, as predicted
by preliminary regression models.

effect of mentholation on serum cotinine
levels was 188 nmol/L (33.2 ng/mL) for
black smokers and 20 nmol/L (3.6 ng/mL)
for white smokers; neither difference was
statistically significant. The authors concluded that higher serum cotinine levels
in black smokers of mentholated cigarettes explained part but not all of the racial difference in serum cotinine levels. In
addition to considering the mentholation
of cigarettes, these authors adjusted the
results for nicotine content of the cigarette, inhalation frequency, how far smokers let their cigarette burn when they
smoked, and weekly exposure to sidestream smoke from the burning end of a
cigarette. The serum levels of thiocyanate, a metabolite of cyanide that reflects
exposure to tobacco smoke, were similar
for the groups when the results were adjusted for the number of cigarettes
smoked per day. This finding suggests
that the higher cotinine levels found
among blacks were not the result of inhaling more smoke than whites do.7
Serum cotinine differences between
black smokers and white smokers have also
been suggested to be attributable to differential reports of the number of cigarettes smoked. Although we did not measure the validity of the study participants’
self-reports, we found no differences in the
reliability of self-reports among blacks,
whites, and Mexican Americans. Clark
and colleagues8 designed a study to determine differences in cigarette smoking reports between 66 blacks and 97 whites.
They collected information about the nicotine content of the cigarette, inhalation frequency, how far smokers let their cigarettes burn when they smoked, and if the
cigarettes were menthol or nonmenthol.
They even measured the lengths of cigarette butts, which were collected for a
week. Clark et al found no evidence that
underreporting of daily cigarette consumption occurred more often in black than in
white smokers and significantly higher seCotinine Differences by Ethnicity—Caraballo et al
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rum cotinine levels in blacks than in whites.
They concluded that the disproportionately high cotinine levels observed in their
study among blacks could not be attributed to reporting error. This result is consistent with our findings. If the study by
Clark et al can be generalized to the US
population, it seems unlikely that reporting differences biased our results.
We also considered differences in selfreported exposure to ETS between the
3 racial and ethnic groups. Even after
adjustment of the results for number of
smokers living in the home, number of
hours of ETS exposure at work, number
of rooms in the home, and region of the
country where the participants lived, the
differences in the relationships between
serum cotinine level and self-reported
cigarette consumption for the 3 racial
groups remained statistically significant. A limitation of this measure, however, is that it relies on self-reports, not
a precise ETS measurement. On the
other hand, chamber study results32 suggest that the ETS exposure generated
by smokers smoking 10 different brands
of US cigarettes is similar, thus providing no basis for believing differential
brand exposure could account for differences observed between black and white
or Mexican American smokers.
Our results documenting differences
betweentheserumcotininelevelsofblack
smokers and white smokers are consistent with results4,13,33-35 documenting differences in serum cotinine levels between
black nonsmokers and white nonsmokers.
In these reports, blacks had higher cotinine levels than whites, even after ETS
exposure and other factors were taken
into account. For example, after adjusting for self-reported levels of ETS exposure, Pirkle and colleagues13 found higher
cotinine levels for blacks than for whites
or Mexican Americans among persons
aged 17 years or older.
Results from our study suggest that differences in serum cotinine levels between blacks and whites cannot be explained by differences in reporting the
number of cigarettes smoked or differences in ETS exposure. The differences
may be influenced by group-specific patterns of smoking behavior and may also be
influenced by differences in nicotine pharmacokinetics and brand mentholation.
Further research is needed to clarify
the relationship between smoking practices and serum cotinine levels in ethnic
groups in the United States. Although
there is no definitive explanation why
blacksmokershavehigherserumcotinine
levels than both whites and Mexican
Americans, this finding is intriguing for 2
reasons: (1) black smokers are more likely
to try to quit but have a lower success rate
than white smokers,36 and (2) blacks in the

United States are at higher risk than
whites of developing and dying from lung
cancer.37 Whether higher serum cotinine
concentrations contribute to higher rates
of nicotine addiction among blacks than
whites is unknown. If higher serum cotinine levels serve as a marker of higher
nicotine intake and absorption, they may
help explain the lower quitting success
rate among black smokers compared with
white smokers. If higher serum cotinine
levels serve as a marker of higher exposure to other cigarette components such
as carcinogenic constituents in cigarette
smoke, they may help explain higher lung
cancer deaths among black smokers compared with white smokers.
Future research should focus on clarifying the independent and interactive influences of race and ethnicity, nicotine
intake, nicotine pharmacokinetics, and
nicotine addiction, as well as the relationship between serum cotinine levels and
the risk for smoking-related diseases. At
present, it is not known whether the differences in serum cotinine levels have
important implications for smoking prevention strategies and public health.
Nonetheless, the racial or ethnic differences observed in this research provide a
plausible basis for consideration of different patterns of tobacco use and related
health consequences.
Jyothi Nagaraja, MS, provided technical and
programming support. We also thank Robert
Robinson, DrPh.
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